As of 2024-12-13, the Relative Valuation of Abbvie Inc (ABBV) is 121.02 USD. This relative valuation is based on P/E multiples. With the latest stock price at 173.19 USD, the upside of Abbvie Inc based on Relative Valuation is -30.1%.
The range of the Relative Valuation is 69.45 - 159.52 USD.
| Range | Selected | |
| Trailing P/E multiples | 24.0x - 32.8x | 30.6x |
| Forward P/E multiples | 28.2x - 43.4x | 41.7x |
| Fair Price | 69.45 - 159.52 | 121.02 |
| Upside | -59.9% - -7.9% | -30.1% |
| Date | P/E |
| 2024-12-12 | 59.75 |
| 2024-12-11 | 60.16 |
| 2024-12-10 | 60.61 |
| 2024-12-09 | 60.92 |
| 2024-12-06 | 60.79 |
| 2024-12-05 | 60.78 |
| 2024-12-04 | 60.88 |
| 2024-12-03 | 62.62 |
| 2024-12-02 | 62.71 |
| 2024-11-29 | 63.11 |
| 2024-11-27 | 63.16 |
| 2024-11-26 | 62.50 |
| 2024-11-25 | 61.09 |
| 2024-11-22 | 61.05 |
| 2024-11-21 | 59.25 |
| 2024-11-20 | 57.88 |
| 2024-11-19 | 57.47 |
| 2024-11-18 | 57.37 |
| 2024-11-15 | 56.92 |
| 2024-11-14 | 58.52 |
| 2024-11-13 | 58.77 |
| 2024-11-12 | 59.03 |
| 2024-11-11 | 60.18 |
| 2024-11-08 | 68.83 |
| 2024-11-07 | 69.18 |
| 2024-11-06 | 69.42 |
| 2024-11-05 | 69.58 |
| 2024-11-04 | 69.16 |
| 2024-11-01 | 70.23 |
| 2024-10-31 | 70.34 |
| 2024-10-30 | 69.52 |
| 2024-10-29 | 65.36 |
| 2024-10-28 | 65.44 |
| 2024-10-25 | 64.81 |
| 2024-10-24 | 65.43 |
| 2024-10-23 | 64.82 |
| 2024-10-22 | 65.12 |
| 2024-10-21 | 64.36 |
| 2024-10-18 | 65.16 |
| 2024-10-17 | 65.06 |
| 2024-10-16 | 65.71 |
| 2024-10-15 | 66.19 |
| 2024-10-14 | 67.50 |
| 2024-10-11 | 67.00 |
| 2024-10-10 | 67.05 |
| 2024-10-09 | 67.19 |
| 2024-10-08 | 66.59 |
| 2024-10-07 | 66.80 |
| 2024-10-04 | 67.03 |
| 2024-10-03 | 67.43 |